| ID | Sponsor | Protocol |
|---|---|---|
| 101 | Axsome Therapeutics | AXS-14-FM-301 |
| 41 | General | General Follow Up |
| 99 | Janssen | JNJ-42847922 |
| 93 | Pfizer | C4951063 |
| 3 | RealTime-CTMS | Enrolling web form |
| 1 | RealTime-CTMS | Future Candidates |
| ID | Sponsor | Protocol |
|---|---|---|
| 101 | Axsome Therapeutics | AXS-14-FM-301 |
| 41 | General | General Follow Up |
| 99 | Janssen | JNJ-42847922 |
| 93 | Pfizer | C4951063 |
| 3 | RealTime-CTMS | Enrolling web form |
| 1 | RealTime-CTMS | Future Candidates |